News
07-15-2009, 05:10 AM
Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research. DACH1, a cell fate determination factor protein, prevents cancer cell proliferation by repressing the function of estrogen receptors in breast cancer, the researchers found.
More... (http://www.medicalnewstoday.com/articles/157523.php)
More... (http://www.medicalnewstoday.com/articles/157523.php)